Synmosa Biopharma (4114.TWO) Earnings Analysis
Synmosa Biopharma (4114.TWO) next reports earnings on 2026-08-18, consensus EPS 0.4075 TWD. Last quarter (2026-03-26) it missed with EPS 0.38 TWD vs 0.584 TWD est (-34.9%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E 18.69.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4114.TWO next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | 0.4075 TWD |
| Revenue estimate | 1.68B |
4114.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | 0.38 TWD | 0.584 TWD | -34.9% | Miss |
| 2025-03-06 | 0.32 TWD | 0.4772 TWD | -32.9% | Miss |
| 2024-11-14 | 0.39 TWD | 0.519 TWD | -24.9% | Miss |
| 2024-08-05 | 0.4438 TWD | 0.4438 TWD | 0% | Beat |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
4114.TWO valuation and analyst view
| Trailing P/E | 18.69 |
|---|---|
| Trailing EPS | 1.509 TWD |
| Price / book | 1.67 |
| Dividend yield | 2.89% |
| Market cap | 15.97B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Synmosa Biopharma (4114.TWO)'s next earnings date?
Synmosa Biopharma is next scheduled to report on 2026-08-18, with a consensus EPS estimate of 0.4075 TWD and revenue estimate of 1.68B.
Did 4114.TWO beat earnings last quarter?
In its 2026-03-26 report, 4114.TWO posted EPS of 0.38 TWD versus a 0.584 TWD estimate — a miss of 34.9%.
What is 4114.TWO's earnings track record?
Over the last 4 reported quarters with consensus data, 4114.TWO beat estimates 1 times (25%).
What is 4114.TWO's current P/E ratio and EPS?
4114.TWO trades at a trailing P/E of 18.69 on trailing EPS of 1.5090840060746542 TWD.
What do analysts rate 4114.TWO?
4114.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.